mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.04 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.04 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.1 |